Details of the Drug Formulaction

General Information of Drug Formulation (ID: F18292)

• Formulation Name: Pyridostigmine 180 mg tablet
• Company: Alvogen

Pharmaceutical Drug(s) in Formulation

Drug Name	Drug ID	Indication	ICD 11	Status
Pyridostigmine	(DM8HO1L)	Myasthenia gravis	8C6Y	Approved

Pharmaceutical Excipient(s) in Formulation

Excipient Name	Excipient ID	PubChem CID	Functional Classification
Calcium phosphate	(E00298)	24456	Anticaking agent; Buffering agent; Desiccant; Diluent
Magnesium stearate	(E00208)	11177	lubricant
Silicon dioxide	(E00670)	Not Available	Anticaking agent; Opacifying agent; Viscosity-controlling agent